Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
124M
-
Number of holders
-
254
-
Total 13F shares, excl. options
-
110M
-
Shares change
-
+1.59M
-
Total reported value, excl. options
-
$2.27B
-
Value change
-
-$27.7M
-
Put/Call ratio
-
0.66
-
Number of buys
-
125
-
Number of sells
-
-159
-
Price
-
$20.63
Significant Holders of Guardant Health, Inc. - Common Stock (GH) as of Q1 2024
369 filings reported holding GH - Guardant Health, Inc. - Common Stock as of Q1 2024.
Guardant Health, Inc. - Common Stock (GH) has 254 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 110M shares
of 124M outstanding shares and own 88.98% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (11.4M shares), BlackRock Inc. (11M shares), BAILLIE GIFFORD & CO (6.23M shares), Deep Track Capital, LP (6M shares), CADIAN CAPITAL MANAGEMENT, LP (5.79M shares), EVENTIDE ASSET MANAGEMENT, LLC (4.18M shares), Temasek Holdings (Private) Ltd (4.11M shares), Capital International Investors (3.82M shares), FMR LLC (3.03M shares), and CITADEL ADVISORS LLC (2.79M shares).
This table shows the top 254 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.